McKenna Mark C. - Insider Non-Derivative Transactions at Prometheus Biosciences, Inc. (RXDX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 16, 2023, McKenna Mark C.'s relationship to Prometheus Biosciences, Inc. (RXDX) is Director,Officer (Chairman, President and CEO), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RXDX insiders.

Data Source: SEC.
McKenna Mark C. - Insider Non-Derivative Transactions of RXDX Common Stock
McKenna Mark C. - Insider Non-Derivative Transactions at RXDX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 17, 2023 Disposition -- (Common Stock) 178098 0 0
Jun 3, 2023 M -- (Common Stock) 122528 2.9 177672
Jun 3, 2023 M -- (Common Stock) 3 1.7 178036
Mar 16, 2023 Sell -- (Common Stock) 25000 116.14 55144
Mar 16, 2023 M -- (Common Stock) 25000 2.9 80144
Mar 4, 2023 Sell -- (Common Stock) 10620 125.13 55144
Mar 4, 2023 M -- (Common Stock) 10620 3.7 65764
Mar 2, 2023 Sell -- (Common Stock) 700 125.26 55144
Mar 2, 2023 M -- (Common Stock) 700 3.7 55844
Feb 18, 2023 Sell -- (Common Stock) 13680 125.1 55144
Feb 18, 2023 M -- (Common Stock) 13680 3.7 68824
Feb 17, 2023 Sell -- (Common Stock) 25000 119.87 55144
Feb 17, 2023 M -- (Common Stock) 25000 3.7 80144
Feb 16, 2023 Sell -- (Common Stock) 25000 119.42 55144
Feb 16, 2023 M -- (Common Stock) 25000 2.9 80144
Jan 18, 2023 Sell -- (Common Stock) 25000 118.99 55144
Jan 18, 2023 M -- (Common Stock) 25000 2.9 80144